FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing asparaginase Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing asparaginase in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only asparaginase in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing calaspargase pegol (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only calaspargase pegol (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing calaspargase pegol in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only calaspargase pegol in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely asparaginase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Asparaginase Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cyclophosphamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cyclophosphamide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cyclophosphamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cyclophosphamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cyclophosphamide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cyclophosphamide 50 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 1 gram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cyclophosphamide 25 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing crizotinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only crizotinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Crizotinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing crizotinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cytarabine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cytarabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cytarabine 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cytarabine 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cytarabine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cytarabine liposome (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cytarabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cytarabine liposome in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tretinoin in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 10 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cisplatin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cisplatin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cisplatin liposome (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cisplatin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cisplatin liposome in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cladribine Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cladribine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cladribine 1 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cladribine Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cladribine in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cladribine in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cladribine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing azacitidine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Azacitidine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing axitinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely axitinib 3 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely axitinib 5 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely axitinib 1 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Axitinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing axitinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only axitinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only copanlisib in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only copanlisib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing copanlisib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing copanlisib in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Clofarabine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing clofarabine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cetuximab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cetuximab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing chlorambucil Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing chlorambucil in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only chlorambucil in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Chlorambucil Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely chlorambucil 2 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing chlormethine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Chlormethine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing busulfan Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only busulfan in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely busulfan 2 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing busulfan in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Busulfan Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing ceritinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only ceritinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ceritinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceritinib 150 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing ceritinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing carmustine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only carmustine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing carmustine in prolonged-release intralesional implant (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing carmustine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carmustine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing carfilzomib in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only carfilzomib in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing carfilzomib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carfilzomib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cemiplimab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing carboplatin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 7 of 26 Next End

This concept is not in any reference sets

Back to Start